WASHINGTON, D.C. — U.S. Congressmen Josh Gottheimer (NJ-5) and John Rutherford (FL-05) relaunched the bipartisan Crohn’s and Colitis Caucus in the 118th Congress.
Both Gottheimer and Rutherford will serve as co-chairs of the caucus, which is dedicated to educating Congress and the American public on Crohn’s disease and ulcerative colitis, collectively known as inflammatory bowel disease (IBD).
“I’m honored to be joining with my colleague Congressman John Rutherford to co-chair the bipartisan Congressional Crohn’s and Colitis Caucus,” Gottheimer said. “We’re going to be bringing both Democrats and Republicans together to boost cutting-edge research, to help find treatments and cures, and to improve the quality of life of those impacted by these diseases.”
“As a co-chair of the Congressional Crohn’s and Colitis Caucus, I am committed to working toward solutions for those living with inflammatory bowel disease,” Rutherford said. “Through our bipartisan efforts this Congress, Representative Gottheimer and I will lead the way forward to secure research funding, raise awareness, and fight for cures. Thank you to the thousands of IBD advocates across the country working alongside us and furthering our goals.”
The Congressional Crohn’s and Colitis Caucus receives support from The Crohn’s & Colitis Foundation, a volunteer-driven organization dedicated to finding cures for Crohn’s disease and ulcerative colitis and improving the quality of life of children and adults affected by these diseases.
“We are grateful that the Congressional Crohn’s & Colitis Caucus is reforming in 2023 and for the leadership from Representatives Rutherford and Gottheimer,” said Laura Wingate, Executive Vice President for Education, Support and Advocacy at The Crohn’s & Colitis Foundation. “The Caucus works to assert the patient perspective in legislative and regulatory decision making, therefore making it vital to IBD patients.”
The Congressional Crohn’s and Colitis Caucus works together to raise awareness, support medical research, protect patient access to care, and educate Congress and Americans on IBD.